Cells of the immune system orchestrate changes in bone cell function

Calcified Tissue International

Volumn 94, Issue 1, 2014, Pages 98-111

  Wythe, Sarah E ^a   Nicolaidou, Vicky ^a   Horwood, Nicole J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Mesenchymal stem cell; Monocytes; Natural killer cells; Osteoblast; Osteoclast; T cells

Indexed keywords

INTERLEUKIN 17; OSTEOCLAST DIFFERENTIATION FACTOR;

B LYMPHOCYTE; CELL INTERACTION; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY DISEASE; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; BONE RESORPTION; HUMANS; IMMUNE SYSTEM; INFLAMMATION; OSTEOCLASTS; OSTEOCYTES; OSTEOGENESIS;

EID: 84893764977     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-013-9764-0     Document Type: Review

References (152)

1. Howard GA et al (1981) Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism. Proc Natl Acad Sci USA 78(5):3204-3208
2. Martin TJ, Sims NA (2005) Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11(2):76-81
3. Tamma R, Zallone A (2012) Osteoblast and osteoclast crosstalks: from OAF to Ephrin. Inflamm Allergy Drug Targets 11(3):196-200
4. Takayanagi H (2012) New developments in osteoimmunology. Nat Rev Rheumatol 8(11):684-689
5. Horton MA et al (1985) On the origin of the osteoclast: the cell surface phenotype of rodent osteoclasts. Calcif Tissue Int 37(1):46-50
6. Quinn JM et al (2000) Fibroblastic stromal cells express receptor activator of NF-kappaB ligand and support osteoclast differentiation. J Bone Miner Res 15(8):1459-1466
7. Soderstrom K et al (2010) Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proc Natl Acad Sci USA 107(29):13028-13033
8. Horwood NJ et al (1999) Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 265(1):144-150
9. Kong YY et al (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402(6759):304-309
10. Shinoda K et al (2003) Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes. Bone 33(4):711-720
11. Rifas L, Arackal S, Weitzmann MN (2003) Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. J Cell Biochem 88(4):650-659
12. Gough AK et al (1994) Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344(8914):23-27
13. Loftus EV Jr et al (2003) Risk of fracture in ulcerative colitis: a population-based study from Olmsted County, Minnesota. Clin Gastroenterol Hepatol 1(6):465-473
14. Magrey M, Khan MA (2010) Osteoporosis in ankylosing spondylitis. Curr Rheumatol Rep 12(5):332-336
15. Spector TD et al (1993) Risk of vertebral fracture in women with rheumatoid arthritis. BMJ 306(6877):558
16. Eyerich S et al (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119(12):3573-3585
17. Murphy CA et al (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198(12):1951-1957
18. Takayanagi H et al (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408(6812):600-605
19. Sato K, Takayanagi H (2006) Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol 18(4):419-426
20. Takayanagi H (2005) Inflammatory bone destruction and osteoimmunology. J Periodontal Res 40(4):287-293
21. Kotake S et al (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103(9):1345-1352
22. Zaiss MM et al (2010) Regulatory T cells protect from local and systemic bone destruction in arthritis. J Immunol 184(12):7238-7246
23. + regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem Biophys Res Commun 357(4):1046-1052
24. Wythe SE et al (2013) Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide. Ann Rheum Dis 72(1):129-135
25. Appel H et al (2006) Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 54(9):2845-2851
26. + and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol 186(4):2672-2680
27. Daoussis D et al (2010) Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 62(1):150-158
28. Appel H et al (2009) Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 60(11):3257-3262
29. Chen HA et al (2010) Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis. J Rheumatol 37(10):2126-2132
30. Vosse D et al (2008) Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis. Rheumatology (Oxford) 47(8):1219-1222
31. Braun J, Baraliakos X (2011) Imaging of axial spondyloarthritis including ankylosing spondylitis. Ann Rheum Dis 70(Suppl 1):i97-i103
32. +CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin. Gut 54(1):78-86
33. Ruutu M et al (2012) Beta-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice. Arthritis Rheum 64(7):2211-2222
34. Pacifici R (2007) T cells and postmenopausal osteoporosis in murine models. Arthritis Res Ther 9(2):102
35. Zaidi M (2007) Skeletal remodeling in health and disease. Nat Med 13(7):791-801
36. Jilka RL et al (1998) Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption. J Clin Invest 101(9):1942-1950
37. Kimble RB et al (1996) Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem 271(46):28890-28897
38. Cenci S et al (2000) Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 106(10):1229-1237
39. Lee SK et al (2006) T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res 21(11):1704-1712
40. Yamaza T et al (2008) Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS One 3(7):e2615
41. Roggia C et al (2001) Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 98(24):13960-13965
42. Li JY et al (2011) Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc Natl Acad Sci USA 108(2):768-773
43. Grassi F et al (2007) Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci USA 104(38):15087-15092
44. Li Y et al (2007) B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 109(9):3839-3848
45. DeSelm CJ et al (2012) IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner. J Cell Biochem 113(9):2895-2902
46. Fox SW, Chambers TJ (2000) Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis. Biochem Biophys Res Commun 276(3):868-872
47. Kotake S et al (2005) IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. Eur J Immunol 35(11):3353-3363
48. Madyastha PR et al (2000) IFN-gamma enhances osteoclast generation in cultures of peripheral blood from osteopetrotic patients and normalizes superoxide production. J Interferon Cytokine Res 20(7):645-652
49. Sato K et al (1992) Prolonged decrease of serum calcium concentration by murine gamma-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice. Cancer Res 52(2):444-449
50. Tohkin M et al (1994) Comparative study of inhibitory effects by murine interferon gamma and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK). Cancer Immunol Immunother 39(3):155-160
51. Arnoldi J, Gerdes J, Flad HD (1990) Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy. Am J Pathol 137(4):749-753
52. + T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 67(6):2804-2809
53. Cenci S et al (2003) Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci USA 100(18):10405-10410
54. Goodman GR et al (1999) Interferon-alpha, unlike interferon-gamma, does not cause bone loss in the rat. Bone 25(4):459-463
55. Key LL Jr et al (1995) Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med 332(24):1594-1599
56. Mann GN et al (1994) Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia. Endocrinology 135(3):1077-1083
57. Rodriguiz RM, Key LL Jr, Ries WL (1993) Combination macrophage-colony stimulating factor and interferon-gamma administration ameliorates the osteopetrotic condition in microphthalmic (mi/mi) mice. Pediatr Res 33(4 Pt 1):384-389
58. Duque G et al (2011) Interferon-gamma plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. J Bone Miner Res 26(7):1472-1483
59. Gao Y et al (2007) IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 117(1):122-132
60. Tyagi AM et al (2012) Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS One 7(9):e44552
61. Goswami J et al (2009) A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. Eur J Immunol 39(10):2831-2839
62. Rivollier A et al (2004) Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104(13):4029-4037
63. Speziani C et al (2007) Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines. Eur J Immunol 37(3):747-757
64. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289(5484):1504-1508
65. + dendritic cells. J Immunol 177(5):3314-3326
66. Maitra R et al (2010) Dendritic cell-mediated in vivo bone resorption. J Immunol 185(3):1485-1491
67. Jacome-Galarza CE et al (2013) Identification, characterization and isolation of a common progenitor for osteoclasts, macrophages and dendritic cells from murine bone marrow and periphery. J Bone Miner Res 28:1203-1213
68. Mizoguchi T et al (2009) Identification of cell cycle-arrested quiescent osteoclast precursors in vivo. J Cell Biol 184(4):541-554
69. Charles JF et al (2012) Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. J Clin Invest 122(12):4592-4605
70. Grcevic D et al (2006) Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos. Clin Exp Immunol 146(1):146-158
71. Gupta N et al (2010) IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage. J Immunol 185(4):2261-2272
72. Paust S, von Andrian UH (2011) Natural killer cell memory. Nat Immunol 12(6):500-508
73. Vivier E et al (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331(6013):44-49
74. Grom AA et al (2003) Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 142(3):292-296
75. Pridgeon C et al (2003) Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright, CD94bright, CD158negative phenotype. Rheumatology (Oxford) 42(7):870-878
76. Lo CK et al (2008) Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production. Arthritis Rheum 58(9):2700-2711
77. Brennan PJ, Brigl M, Brenner MB (2013) Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 13(2):101-117
78. Godfrey DI, Rossjohn J (2011) New ways to turn on NKT cells. J Exp Med 208(6):1121-1125
79. Hu M et al (2011) Activated invariant NKT cells regulate osteoclast development and function. J Immunol 186(5):2910-2917
80. Mauri C, Bosma A (2012) Immune regulatory function of B cells. Annu Rev Immunol 30:221-241
81. Blin-Wakkach C et al (2004) Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mice. J Bone Miner Res 19(7):1137-1143
82. Dougall WC et al (1999) RANK is essential for osteoclast and lymph node development. Genes Dev 13(18):2412-2424
83. Kong YY et al (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397(6717):315-323
84. Yun TJ et al (2001) Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function. J Immunol 166(3):1482-1491
85. Weitzmann MN et al (2000) B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta. J Cell Biochem 78(2):318-324
86. Li Y et al (2007) Ovariectomy-induced bone loss occurs independently of B cells. J Cell Biochem 100(6):1370-1375
87. Raggatt LJ et al (2013) Absence of B cells does not compromise intramembranous bone formation during healing in a tibial injury model. Am J Pathol 182(5):1501-1508
88. Nakken B et al (2011) B-cells and their targeting in rheumatoid arthritis - current concepts and future perspectives. Autoimmun Rev 11(1):28-34
89. Bluml S et al (2013) B-cell targeted therapeutics in clinical development. Arthritis Res Ther 15(Suppl 1):S4
90. Loutis N, Bruckner P, Pataki A (1988) Induction of erosive arthritis in mice after passive transfer of anti-type II collagen antibodies. Agents Actions 25(3-4):352-359
91. Taylor PC, Plater-Zyberk C, Maini RN (1995) The role of the B cells in the adoptive transfer of collagen-induced arthritis from DBA/1 (H-2q) to SCID (H-2d) mice. Eur J Immunolo 25(3):763-769
92. Svensson L et al (1998) B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 111(3):521-526
93. Edwards JC, Leandro MJ, Cambridge G (2002) B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders. Biochem Soc Trans 30(4):824-828
94. Moore J et al (2004) A phase II study of rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation. Bone Marrow Transplant 34(3):241-247
95. Horwood NJ, Urbaniak AM, Danks L (2012) Tec family kinases in inflammation and disease. Int Rev Immunol 31(2):87-103
96. Bedi B et al (2012) Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH. Proc Natl Acad Sci USA 109(12):E725-E733
97. Bar-Shavit Z (2007) The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. J Cell Biochem 102(5):1130-1139
98. Nakagawa H et al (1993) Influence of monocyte-macrophage lineage cells on alkaline phosphatase activity of developing osteoblasts derived from rat bone marrow stromal cells. Nippon Seikeigeka Gakkai Zasshi 67(5):480-489
99. Rifas L et al (1989) Monokines produced by macrophages stimulate the growth of osteoblasts. Connect Tissue Res 23(2-3):163-178
100. Champagne CM et al (2002) Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone 30(1):26-31
101. Hume DA, Loutit JF, Gordon S (1984) The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: macrophages of bone and associated connective tissue. J Cell Sci 66:189-194
102. Chang MK et al (2008) Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol 181(2):1232-1244
103. Alexander KA et al (2011) Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res 26(7):1517-1532
104. Nicolaidou V et al (2012) Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation. PLoS One 7(7):e39871
105. Guihard P et al (2012) Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling. Stem Cells 30(4):762-772
106. Zarling JM et al (1986) Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci USA 83(24):9739-9743
107. Walker EC et al (2010) Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J Clin Invest 120(2):582-592
108. Malik N et al (1995) Developmental abnormalities in mice transgenic for bovine oncostatin M. Mol Cell Biol 15(5):2349-2358
109. de Hooge AS et al (2002) Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. Am J Pathol 160(5):1733-1743
110. Levy JB et al (1996) Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells. Endocrinology 137(4):1159-1165
111. Bellido T et al (1997) Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinology 138(9):3666-3676
112. Fujio Y et al (2004) Signals through gp130 upregulate Wnt5a and contribute to cell adhesion in cardiac myocytes. FEBS Lett 573(1-3):202-206
113. Katoh M (2007) STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer. Int J Mol Med 19(2):273-278
114. Botelho FM, Edwards DR, Richards CD (1998) Oncostatin M stimulates c-Fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter. J Biol Chem 273(9):5211-5218
115. Jochum W et al (2000) Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med 6(9):980-984
116. Sabatakos G et al (2000) Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med 6(9):985-990
117. Sims NA, Walsh NC (2010) GP130 cytokines and bone remodelling in health and disease. BMB Rep 43(8):513-523
118. Hamilton TA (2002) Molecular basis of macrophage activation: from gene expression to phenotypic diversity. In: Bourke BL (ed) The macrophage, 2nd edn. Oxford University Press, Oxford
119. Porta C et al (2009) Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci USA 106(35):14978-14983
120. Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122(3):787-795
121. Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32(5):593-604
122. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958-969
123. Fleetwood AJ et al (2007) Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol 178(8):5245-5252
124. Smith W, Feldmann M, Londei M (1998) Human macrophages induced in vitro by macrophage colony-stimulating factor are deficient in IL-12 production. Eur J Immunol 28(8):2498-2507
125. Tadokoro CE, de Almeida AI (2001) Bone marrow-derived macrophages grown in GM-CSF or M-CSF differ in their ability to produce IL-12 and to induce IFN-gamma production after stimulation with Trypanosoma cruzi antigens. Immunol Lett 77(1):31-38
126. Verreck FA et al (2006) Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol 79(2):285-293
127. Hamilton JA (2008) Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8(7):533-544
128. Groh ME et al (2005) Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 33(8):928-934
129. Francois M et al (2012) Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 20(1):187-195
130. Kim J, Hematti P (2009) Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 37(12):1445-1453
131. Maggini J et al (2010) Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 5(2):e9252
132. 2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15(1):42-49
133. Jones S et al (2007) The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol 179(5):2824-2831
134. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105(4):1815-1822
135. Kawaguchi H et al (1995) The role of prostaglandins in the regulation of bone metabolism. Clin Orthop Relat Res 313:36-46
136. Li L et al (2006) Regulation of bone biology by prostaglandin endoperoxide H synthases (PGHS): a rose by any other name. Cytokine Growth Factor Rev 17(3):203-216
137. Xie C et al (2008) COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing. Bone 43(6):1075-1083
138. 2 on mineralization of bone nodules formed by fetal rat calvarial cells. Calcif Tissue Int 55(6):451-457
139. 4-selective agonist (ONO-4819) increases bone formation by modulating mesenchymal cell differentiation. Eur J Pharmacol 650(1):396-402
140. 2 in young rats increases the osteogenic capacity of bone marrow. Bone 20(6):521-526
141. 2 is a novel inducer of oncostatin-M expression in macrophages and microglia. J Neurosci 22(13):5334-5343
142. Bystrom J et al (2008) Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 112(10):4117-4127
143. Rajakariar R et al (2008) Novel biphasic role for lymphocytes revealed during resolving inflammation. Blood 111(8):4184-4192
144. Pettit AR et al (2008) Osteal macrophages: a new twist on coupling during bone dynamics. Bone 43(6):976-982
145. Ren G et al (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2(2):141-150
146. Chen L et al (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3(4):e1886
147. Xu W et al (2006) IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 107(12):4930-4937
148. Kawanaka N et al (2002) CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 46(10):2578-2586
149. + monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum 64(3):671-677
150. Chiappetta N, Gruber B (2006) The role of mast cells in osteoporosis. Semin Arthritis Rheum 36(1):32-36
151. Seitz S et al (2013) Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis. Osteoporos Int 24:2325-2334
152. Martin T, Gooi JH, Sims NA (2009) Molecular mechanisms in coupling of bone formation to resorption. Crit Rev Eukaryot Gene Expr 19(1):73-88